Literature DB >> 15198727

Leukaemia -- a developmental perspective.

Shai Izraeli1.   

Abstract

Leukaemia is characterized by the accumulation of malignant haematopoietic precursors. Recent studies have revealed that acquired alterations in genes that regulate normal haematopoiesis are frequently detected in leukaemia. The progression to leukaemia depends on additional mutations that promote the survival of developmentally arrested cells. This review describes three examples of this general paradigm of leukaemogenesis: RUNX1 abnormalities in acute leukaemias, GATA1 mutations in the leukaemias of Down syndrome, and SCL and LMO2 ectopic expression in T cell acute lymphoblastic leukaemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198727     DOI: 10.1111/j.1365-2141.2004.04986.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 2.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

Review 3.  Transient leukemia in a newborn without Down syndrome: case report and review of the literature.

Authors:  Laurence Rozen; Sophie Huybrechts; Laurence Dedeken; Catherine Heijmans; Barbara Dessars; Pierre Heimann; Frédéric Lambert; Denis F Noubouossie; Alina Ferster; Anne Demulder
Journal:  Eur J Pediatr       Date:  2013-11-20       Impact factor: 3.183

Review 4.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 5.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

6.  Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes.

Authors:  Shannon L McKinney-Freeman; Claudia Lengerke; Il-Ho Jang; Sabine Schmitt; Yuan Wang; Marsha Philitas; Jessica Shea; George Q Daley
Journal:  Blood       Date:  2008-02-05       Impact factor: 22.113

7.  Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.

Authors:  Chen Shochat; Noa Tal; Obul R Bandapalli; Chiara Palmi; Ithamar Ganmore; Geertruy te Kronnie; Gunnar Cario; Giovanni Cazzaniga; Andreas E Kulozik; Martin Stanulla; Martin Schrappe; Andrea Biondi; Giuseppe Basso; Dani Bercovich; Martina U Muckenthaler; Shai Izraeli
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

8.  The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA.

Authors:  Vitalyi Senyuk; Kavitha Premanand; Peng Xu; Zhijian Qian; Giuseppina Nucifora
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

Review 9.  Caudal genes in blood development and leukemia.

Authors:  Claudia Lengerke; George Q Daley
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

10.  The transcriptional landscape of hematopoietic stem cell ontogeny.

Authors:  Shannon McKinney-Freeman; Patrick Cahan; Hu Li; Scott A Lacadie; Hsuan-Ting Huang; Matthew Curran; Sabine Loewer; Olaia Naveiras; Katie L Kathrein; Martina Konantz; Erin M Langdon; Claudia Lengerke; Leonard I Zon; James J Collins; George Q Daley
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.